COVID-19 and Cannabis - where are we from a research and clinical care perspective?
With COVID-19 still continuing to spread, researchers around the world have been looking into medical cannabis as a potential treatment or prevention for COVID-19. While it is too early to tell definitive results, some preliminary findings are showing promise.
This virtual event will bring together researchers and clinicians from around the world who are studying the potential effects of certain cannabis extracts and cannabinoids have on COVID-19 the impact of the virus on medical cannabis patients and adult use cannabis consumers.
Date: Dec 9th, 2020
Time: 12:00 PM - 2:00 PM EST
Will present data from a recently published pre-print study reporting hemp extracts high in CBD and its potential to block proteins that provide a “gateway” for COVID-19 to enter host cells.
Dr. Denise Vidot, Assistant Professor in the School of Nursing and Health Sciences at the University of Miami
Present findings from University of Miami Cannabis Consumers and Patients study with COVID-19.
Kebra will present about the clinical impacts of COVID-19 on cannabis patients.
Impact of COVID-19 on public health and safety in cannabis - what does the future look like?
Dr. Mohan recently published an article SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?. Brain Behav Immun. 2020;87:120-121. doi:10.1016/j.bbi.2020.04.079. The authors conclusion “Collectively, these findings support the investigation of cannabinoids as a plausible option to be added as an adjunct to Remdesivir or any new antivirals on SARS-CoV2 induced lung inflammation”
Cannabis and COVID-19 research study with UMass Dartmouth
- Jason Nelson, Senior Vice President of Horticulture at Cresco Labs
- Kathleen McKinnon, Alternative Wellness Centers